Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway

Mary D L Chau1, Jiaping Gao, Qing Yang

  • 1Cardiovascular and Metabolism Disease Area, Novartis Institute for Biomedical Research, Inc., Cambridge, MA 02139, USA.

Insights

Fibroblast growth factor 21 (FGF21) enhances energy homeostasis by activating AMPK and SIRT1 in fat cells. This boosts mitochondrial function, improving glucose and lipid metabolism.

Area of Science:

  • Metabolic Regulation
  • Cellular Metabolism
  • Obesity and Diabetes Research

Background:

  • Fibroblast growth factor 21 (FGF21) is a key metabolic regulator with demonstrated benefits in obesity and diabetes models.
  • The precise molecular mechanisms underlying FGF21's metabolic regulatory functions are not fully understood.

Purpose of the Study:

  • To elucidate the mechanisms by which FGF21 regulates energy homeostasis in adipocytes.
  • To investigate the role of AMP-activated protein kinase (AMPK) and sirtuin 1 (SIRT1) in FGF21's metabolic actions.

Main Methods:

  • Investigated FGF21 effects on adipocytes and white adipose tissue from ob/ob mice.
  • Measured AMPK phosphorylation, cellular NAD(+) levels, and SIRT1 activity.
  • Assessed mitochondrial oxidative function via oxygen consumption and citrate synthase activity.
  • Examined the involvement of serine/threonine kinase 11 (STK11/LKB1) and downstream targets like PGC-1alpha.

Main Results:

  • FGF21 treatment increased AMPK phosphorylation and NAD(+) levels in adipocytes.
  • FGF21 activated SIRT1, leading to deacetylation of PGC-1alpha and histone 3.
  • Enhanced mitochondrial oxidative capacity was observed, evidenced by increased oxygen consumption and citrate synthase activity.
  • FGF21's effects were dependent on STK11/LKB1, AMPK, SIRT1, and PGC-1alpha.

Conclusions:

  • FGF21 regulates energy homeostasis in adipocytes through an AMPK-SIRT1-PGC1alpha signaling pathway.
  • This pathway enhances mitochondrial oxidative capacity, contributing to FGF21's metabolic benefits.
  • Understanding this mechanism provides insight into potential therapeutic strategies for metabolic disorders.

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Regulation of Metabolism01:19

Regulation of Metabolism

Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...